TUESDAY, SEPTEMBER 19, 2017

Seattle BioMed receives $9.8 million grant for HIV vaccine

Seattle BioMed, an independent, non-profit organization, announced on Tuesday that it received a $9.8 million grant from the National Institutes of Health to develop an HIV vaccine. Read More »

Flu vaccination rule for day care reduces hospitalization rate

Flu vaccine Read More »

The Brewer Group and TNI BioTech join in strategic partnership

The Brewer Group, Inc., announced a partnership with TNI BioTech, Inc., on Friday to develop affordable treatment technologies for as low at $1 per day for people in need in various markets across the globe. Read More »

Three-year-old Cambodian boy dies from H5N1 influenza infection

H5N1 Read More »

New York investigates measles outbreak in Manhattan, Bronx

The New York City Department of Health and Mental Hygiene announced on Friday that it identified 16 cases of measles in northern Manhattan and the Bronx, including nine pediatric cases. Read More »

Alaska reports cluster of chickenpox cases

Chickenpox Read More »

Tuberculosis vaccine Phase II trial begins in South Africa

Tuberculosis Read More »

Meningitis outbreak in Uganda continues

Meningococcal bacteria Read More »

Novavax appoints new senior vice president of commercial operations

Novavax, Inc., a clinical-stage biopharmaceutical company, announced on Monday that it appointed John Trizzino to the position of senior vice president of commercial operations. Read More »

SC Johnson launches initiatives to fight mosquito-borne diseases

Mosquito Read More »

Individual with lupus and HIV exhibits desired immune response to HIV

HIV Read More »

Global Fund updates initiative to fight global gender inequality

The Global Fund to Fight HIV, Tuberculosis and Malaria recently met to revisit its gender equality campaign to address new challenges in reaching underserved female populations with its health initiatives. Read More »

Researchers produce molecule to kill malaria without harming blood cells

Malaria Read More »

Romark partners with DSG for trial of investigational influenza treatment

Romark Laboratories recently announced that it will conduct a Phase III clinical trial of its investigational influenza treatment Nitazoxanide, also known as NT-300, with help from DSG, Inc. Read More »

Cases of whooping cough continue to increase in Idaho

Pertussis Read More »

MBio has successful Phase I trial of point-of-care TB assay

MBio Diagnostics, Inc., recently presented the Phase I results of a study that tested the efficacy of its multiplexed immunoassay platform. Read More »

Hong Kong Centre for Health Protection monitors increased measles activity

The Hong Kong Department of Health's Centre for Health Protection said on Wednesday that cases of measles have increased in number in Hong Kong and neighboring areas, and it is closely monitoring the activity. Read More »

EPFL and AN Bach Institute develop effective antibiotic against multi-resistant TB

Tuberculosis Read More »

WHO monitors three cases of Middle East respiratory syndrome coronavirus

MERS-CoV Read More »

Enigma Diagnostics awarded $1.9M grant for development of rapid MDR-TB POC assay

Enigma Diagnostics announced that it was awarded a second grant from the United Kingdom's Technology Strategy Board worth $1.9 million for the development of its multi-drug resistant tuberculosis point-of-care assay. Read More »